SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...

Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif. & ...

Agilent Technologies Inc. and Cogenics, a division of Clinical Data, Inc. have announced that Cogenics has been recertified, for the third year, as a Certified Microarray Service Provider for Agilent ...

PALO ALTO, Calif., Aug. 7, 2006, Agilent Technologies Inc. (NYSE: A) today announced the availability of oligo array-based ChIP-on-chip (chromatin immunoprecipitation on a chip) microarrays with a ...

Agilent Technologies Inc. (NYSE: A) today announced that it has signed two new partners and recertified one more as Certified Microarray Service Providers for Agilent microarrays. Each of these ...

Agilent’s SurePrint microarray technology features a flexible, industrial-scale inkjet printing process that synthesizes oligonucleotide probes in situ onto 1“ x 3“ slides. The maskless process allows ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression ...

The Microarray Core Facility is a component of the UAlbany Center for Functional Genomics and was established to provide the infrastructure to enable the development of major projects that utilize DNA ...

Yes, many are attracted to next-generation sequencing, but loyalty to chip-based phenotyping has its rewards, particularly in screens of large sample sets. The microarray, the legacy technology for ...

The DNA marketplace is changing: the technology is maturing, whole human genome arrays, as well as those of model organisms, are beginning to make it onto the market, and researchers have more choices ...